Literature DB >> 19965924

Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.

Richard S Legro1, Rebecca L Roller, William C Dodson, Christina M Stetter, Allen R Kunselman, Andrea Dunaif.   

Abstract

CONTEXT: Low birthweight has been associated with metabolic and reproductive abnormalities in adults.
OBJECTIVE: The aim of the study was to examine the relationship between birthweight and gestational age and its association with reproductive and metabolic phenotypes in women with PCOS and their first-degree relatives. DESIGN AND
SETTING: We conducted a family-based study of PCOS at an academic health center. PATIENTS OR OTHER PARTICIPANTS: A total of 1038 individuals (845 females and 193 males) from the cohort and 168 controls participated in the study. MAIN OUTCOME MEASURES: The association between birthweight and familial phenotype was measured.
RESULTS: Self-reported and actual birthweight were highly correlated [Spearman correlation coefficient (r) = 0.81; 95% CI, 0.66, 0.89; P = 0.001) and concordant (concordance correlation coefficient = 0.86; 95% lower limit = 0.78). We noted that birthweight for both genders in PCOS families and controls fell within the 10th and 90th percentiles for gestational age based on U.S. population norms. The 50th percentiles for a gestational age of 40 wk were very similar (3409 g in PCOS, 3455 g for controls, and 3495 g for the United States). There were no significant associations between phenotype and birthweight in PCOS probands. Furthermore, there were not any significant relationships between phenotype and birthweight in female or male family members of the PCOS probands.
CONCLUSIONS: Birthweight in PCOS families mirrors control and U.S. population data, even corrected for gestational age, and has no substantive association with reproductive and metabolic abnormalities in women with PCOS, their female relatives, or their male relatives.

Entities:  

Mesh:

Year:  2009        PMID: 19965924      PMCID: PMC2840854          DOI: 10.1210/jc.2009-1849

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  57 in total

1.  Fetal growth, length of gestation, and polycystic ovaries in adult life.

Authors:  J L Cresswell; D J Barker; C Osmond; P Egger; D I Phillips; R B Fraser
Journal:  Lancet       Date:  1997-10-18       Impact factor: 79.321

2.  Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature.

Authors:  C M Law; A W Shiell
Journal:  J Hypertens       Date:  1996-08       Impact factor: 4.844

3.  A United States national reference for fetal growth.

Authors:  G R Alexander; J H Himes; R B Kaufman; J Mor; M Kogan
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

Review 4.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

5.  Self-reported birthweight and history of having been breastfed among younger women: an assessment of validity.

Authors:  L M Troy; K B Michels; D J Hunter; D Spiegelman; J E Manson; G A Colditz; M J Stampfer; W C Willett
Journal:  Int J Epidemiol       Date:  1996-02       Impact factor: 7.196

6.  Growth in utero and serum cholesterol concentrations in adult life.

Authors:  D J Barker; C N Martyn; C Osmond; C N Hales; C H Fall
Journal:  BMJ       Date:  1993-12-11

7.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

Authors:  L Ibáñez; N Potau; I Francois; F de Zegher
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

9.  Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  L Ghizzoni; R Virdis; A Vottero; M Cappa; M E Street; M Zampolli; L Ibañez; S Bernasconi
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

10.  Agreement between maternal interview- and medical record-based gestational age.

Authors:  R B Hakim; J M Tielsch; L C See
Journal:  Am J Epidemiol       Date:  1992-09-01       Impact factor: 4.897

View more
  20 in total

Review 1.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 2.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

3.  Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome.

Authors:  Jessica Carroll; Richa Saxena; Corrine K Welt
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

Review 4.  Intrauterine environment and polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Mark O Goodarzi; Gregorio D Chazenbalk; David H Abbott
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

5.  Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction.

Authors:  Violanda Grigorescu; Yujia Zhang; Dmitry M Kissin; Erin Sauber-Schatz; Mithi Sunderam; Russell S Kirby; Hafsatou Diop; Patricia McKane; Denise J Jamieson
Journal:  Fertil Steril       Date:  2014-01-30       Impact factor: 7.329

6.  Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.

Authors:  Helen Anderson; Naomi Fogel; Stefan K Grebe; Ravinder J Singh; Robert L Taylor; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2010-03-12       Impact factor: 5.958

7.  Update: consequences of abnormal fetal growth.

Authors:  Steven D Chernausek
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

8.  Developmental programming: exposure to testosterone excess disrupts steroidal and metabolic environment in pregnant sheep.

Authors:  B Abi Salloum; A Veiga-Lopez; D H Abbott; C F Burant; V Padmanabhan
Journal:  Endocrinology       Date:  2015-03-12       Impact factor: 4.736

Review 9.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 10.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.